Jim Bartel Named Chief Executive Officer of Vantage MedTech
Jim Bartel Named Chief Executive Officer of Vantage MedTech
LENEXA, Kan. and MOONACHIE, N.J., April 23, 2024 /PRNewswire/ -- Vantage MedTech ("Vantage"), a leading provider of comprehensive design and manufacturing services for medical technology innovations, is pleased to announce the appointment of Jim Bartel as Chief Executive Officer.
堪薩斯州萊內克薩和新澤西州穆納奇，2024年4月23日 /PRNewswire/ — 醫療技術創新綜合設計和製造服務的領先提供商Vantage MedTech（“Vantage”）很高興地宣佈任命吉姆·巴特爾爲首席執行官。
Mr. Bartel brings over 25 years of leadership experience within medical device and contract manufacturing organizations, including roles leading marketing, business development, and sales teams. With a passion for services and manufacturing, Mr. Bartel has a deep understanding of product development and building high-performing teams that share common values to accelerate growth.
Bartel 先生在醫療器械和合同製造組織中擁有超過 25 年的領導經驗，包括領導營銷、業務開發和銷售團隊。Bartel 先生對服務和製造業充滿熱情，對產品開發和建立具有共同價值觀的高績效團隊有着深刻的理解，以加速增長。
He most recently served as CEO and Board Member of Waltek, Inc., a private equity-owned casting and machining company serving the medical industry, and President of Spectralytics, Inc., a medical device contract manufacturing organization, in addition to being COO and Board Member of Precision ADM, a 3D metal contract manufacturing company. He also spent four years at Stratasys, the leading 3D printing company, as VP and General Manager of their rapid prototyping business unit. Mr. Bartel holds a B.A., dual majors, in Economics and Management from Hartwick College and an M.B.A., focused on Business, Management, and Marketing, from the University of St. Thomas, Opus College of Business.
除了擔任三維金屬合約製造公司Precision ADM的首席運營官兼董事會成員外，他最近還擔任過Waltek, Inc.（一家爲醫療行業服務的私募股權鑄造和加工公司）的首席執行官兼董事會成員，以及醫療器械合同製造組織Spectralytics, Inc. 的總裁。他還在領先的 3D 打印公司 Stratasys 工作了四年，擔任快速原型製作業務部門的副總裁兼總經理。Bartel 先生擁有哈特威克學院經濟與管理雙專業學士學位和聖托馬斯大學歐普斯商學院工商管理碩士學位，主修商業、管理和市場營銷。
Upon his appointment as CEO, Mr. Bartel commented, "Vantage has been on an exciting growth journey, and I'm grateful for the opportunity to serve as CEO. We have a talented team of 150+ medical device engineers with decades of industry expertise. Their dedication to partnering with medical device innovators from concept to realization is what makes Vantage stand apart and is key to our long term success."
在被任命爲首席執行官後，巴特爾先生評論說：“Vantage一直處於激動人心的增長之旅中，我很感激有機會擔任首席執行官。我們擁有一支由 150 多名醫療器械工程師組成的才華橫溢的團隊，他們擁有數十年的行業專業知識。從概念到實現，他們致力於與醫療器械創新者合作，這使Vantage脫穎而出，也是我們長期成功的關鍵。”
Vantage is backed by Boston-based private equity firm Ampersand Capital Partners ("Ampersand"). Trevor Wahlbrink, Partner at Ampersand added "We are thrilled to have Jim join the Vantage team given his exceptional leadership qualities and deep understanding of contract services companies serving the medical device industry. His experience, commitment to quality, and teamwork mentality will prove invaluable to Vantage's growth strategy."
Vantage由總部位於波士頓的私募股權公司Ampersand Capital Partners（“Ampersand”）提供支持。Ampersand合夥人Trevor Wahlbrink補充說：“我們很高興Jim加入Vantage團隊，因爲他具有卓越的領導才能以及對服務於醫療器械行業的合同服務公司的深刻理解。他的經驗、對質量的承諾和團隊合作心態將證明對Vantage的增長戰略非常寶貴。”
About Vantage MedTech
關於 Vantage MedTech
Vantage MedTech provides comprehensive design and manufacturing services, supporting the advancement of medical technologies from concept through to product realization. Partnering with the world's most innovative MedTech start-ups and large medical device companies, we offer feasibility support, product development and prototyping, clinical and commercial manufacturing, and after-market services to support every phase of the product life cycle. Our clients can leverage our proprietary Advantage Platforms, accelerating product development timelines. Our manufacturing approach is structured to serve the changing needs of our clients, supporting small-quantity clinical or First-in-Human builds and can scale to accommodate full launch quantities. Vantage MedTech has facilities in Moonachie, New Jersey and Lenexa, Kansas. Additional information is available at available at VantageMedTech.com and on LinkedIn.
Vantage MedTech 提供全面的設計和製造服務，支持醫療技術從概念到產品實現的發展。我們與世界上最具創新性的醫療科技初創企業和大型醫療器械公司合作，提供可行性支持、產品開發和原型設計、臨床和商業製造以及售後服務，爲產品生命週期的每個階段提供支持。我們的客戶可以利用我們專有的優勢平台，加快產品開發進度。我們的製造方法旨在滿足客戶不斷變化的需求，支持小批量臨床或首次人體建造，並且可以擴展以適應全部發射量。Vantage MedTech在新澤西州的穆納奇和堪薩斯州的萊內克薩設有工廠。更多信息可在VantageMedtech.com和LinkedIn上獲得。
About Ampersand Capital Partners
關於安珀桑資本合夥人
Founded in 1988, Ampersand Capital Partners is a middle market private equity firm with $3 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors. For additional information, visit Ampersandcapital.com or follow us on LinkedIn.
Ampersand Capital Partners成立於1988年，是一家中間市場私募股權公司，管理着30億美元的資產，專門用於醫療保健領域的增長導向型投資。Ampersand 在馬薩諸塞州波士頓和荷蘭阿姆斯特丹設有辦事處，利用私募股權和運營經驗的獨特組合，與其投資組合公司管理團隊一起創造價值並推動長期業績。Ampersand 在公司的每個核心醫療保健領域幫助建立了衆多市場領先的公司。欲了解更多信息，請訪問 AmpersandCapital.com 或在 LinkedIn 上關注我們。
Contact:
Emily Shores
913-385-5700
[email protected]
聯繫人：
艾米麗海岸
913-385-5700
[電子郵件保護]
SOURCE Vantage MedTech
來源 Vantage MedTech
譯文內容由第三人軟體翻譯。